“Morphologic Leukemia-Free State After Venetoclax-Based Therapy in Acute Myeloid Leukemia Is Associated With High Relapse Despite Preserved Short-Term Survival”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 18, no. 1, Apr. 2026, p. e2026048, https://doi.org/10.4084/MJHID.2026.048.